A process for preparing human prothrombin complex by flow adsorption method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 华润博雅生物制药集团股份有限公司
- Publication Date
- 2021-11-30
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation process of a human prothrombin complex, which belongs to the field of biopharmaceuticals, in particular to a process for preparing a human prothrombin complex by a flow adsorption method. Background technique
[0002] Human prothrombin complex (Prothrombin Complex Concentrate, PCC) is an intravenous plasma protein preparation that can promote blood coagulation, which is isolated from the mixed plasma of healthy people. It is generally called factor IX concentrated preparation. PCC mainly contains vitamin K-dependent prothrombin (FII), stable factor (FVII), plasma thromboplastin component (FIX) and Stuart-Prower factor (FX). The plasma concentration of various coagulation factor proteins in PCC is between 1 and 200 mg / L, and they all belong to serine proteases, which exist in the form of inactive zymogens in the blood circulation. Since these factors belong to glycoproteins, are synthesized in the liver, and are m...